{
  "id": 10869723,
  "title": "Nigeria: Nigeria Among High-Volume Markets for New $1 HIV, Syphilis, Hepatitis B Testing Bundle",
  "url": "https://urgent.news/2026/09/30/nigeria-nigeria-among-high-volume-markets-for-new-1-hiv-syphilis",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T05:19:27.000Z",
  "source": {
    "name": "AllAfrica Health",
    "slug": "allafrica-health",
    "url": "https://allafrica.com/stories/202609300068.html"
  },
  "original_language": "en",
  "account": "The new $1 testing bundle for HIV, syphilis, and hepatitis B is set to expand screening in Nigeria, as identified by analysis from Premier Medical Corporation and Impact Nexus Africa. This package, which combines two rapid diagnostic tests for $1 per woman, aims to reach high-volume markets such as Nigeria, Ethiopia, Tanzania, Uganda, Kenya, Mozambique, and South Africa. If adopted, the bundle could generate $215 million in commodity savings across 74 low- and middle-income countries between 2026 and 2035. In Nigeria specifically, only 12.3% of pregnant women were tested for hepatitis B in the 2026 Demographic and Health Survey, highlighting the potential impact of this affordable screening option.",
  "summary": "[Premium Times] The companies said their analysis identified Nigeria, Ethiopia, Tanzania, Uganda, Kenya, Mozambique and South Africa among the countries with the largest potential markets for antenatal hepatitis B screening.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}